I highly doubt that ALA will ever reach $1 or achieve a MC of $840 million. The company is being positioned for a sale and will likely be acquired well before reaching $1, especially if its results align with the preferences of a larger pharma.
For what it's worth, Mink Therapeutics (INKT) hit a low of $1 in early May but has since rebounded to $3.30 (+22% last night), with a MC of A$165 million.
Ann: Becoming a substantial holder RM, page-5
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $200.6M | |||
| Open | High | Low | Value | Volume |
| 18.8¢ | 19.0¢ | 18.5¢ | $115.0K | 609.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 226209 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 791369 | 7 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |